期刊文献+

冠心病患者阿司匹林抵抗的危险因素

原文传递
导出
摘要 目的:探讨冠心病患者阿司匹林抵抗的危险因素。方法:收集我院200例冠心病患者,根据患者是否诊断为阿司匹林抵抗[3],进行分组:100例研究组(发生阿司匹林抵抗)和100例对照组(未发生阿司匹林抵抗)。对比两组一般资料及实验室指标。结果:(1)研究组和对照组一般资料(年龄、体重指数、吸烟史、饮酒史、高血压史)比较无差异(P>0.05)(2)两组实验室指标(血小板计数、空腹血糖、总胆固醇)及糖尿病史比较有差异(P<0.05);两组实验室指标(尿素氮、甘油三酯)比较无差异(P>0.05)。结论:冠心病患者阿司匹林抵抗与血小板数量上升、高血糖、总胆固醇水平上升有关,应该对此类患者进行进行积极干预。
作者 刘慧萍
出处 《健康之路》 2017年第2期84-85,共2页 Health Way
  • 相关文献

参考文献3

二级参考文献48

  • 1[1]Helgason CM, Bolion KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke, 1994, 25:2331
  • 2[2]Hung J, Lam JY, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation, 1995, 92:2432
  • 3[3]Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinical. Can J Cardiol, 1995,11:221
  • 4[4]Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost,1997, 78:1003
  • 5[5]Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res, 1993, 71:397
  • 6[6]Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med, 1998, 339:1665
  • 7[7]Alexander JH, Harrington RA, Tuttle RH, et al. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet Ⅱb/Ⅲa in unstable angina: receptor suppression using integrilin therapy. Am J Cardiol, 1999, 83:1147
  • 8[8]Taylor DW, Bamett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet, 1999, 353:2179
  • 9[1]Haubelt H,Anders C,Hellstern P.Can platelet function tests predict the clinical efficacy of aspirin?[J].Semin Thromb Hemost,2005,31 (4):404-410.
  • 10[2]Halushka MK,Walker LP,Halushka PV.Genetic variation in cyclooxygenase 1:effects on response to aspirin[J].Clin Pharmacol Ther,2003,73(1):122-130.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部